These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 37981190)

  • 1. Baroreflex activation therapy in patients with heart failure and reduced ejection fraction.
    Cordero Pereda D; de Rueda Panadero C; de Juan Bagudá J; Gómez Bueno M; Robles-Mezcua A; Álvarez-García J
    Rev Esp Cardiol (Engl Ed); 2024 Apr; 77(4):342-344. PubMed ID: 37981190
    [No Abstract]   [Full Text] [Related]  

  • 2. Baroreflex Activation Therapy in Patients with Heart Failure with a Reduced Ejection Fraction.
    Ruddy JM; Kroman A; Baicu CF; Zile MR
    Heart Fail Clin; 2024 Jan; 20(1):39-50. PubMed ID: 37953020
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Baroreflex Activation Therapy in Patients With Heart Failure With Reduced Ejection Fraction.
    Zile MR; Lindenfeld J; Weaver FA; Zannad F; Galle E; Rogers T; Abraham WT
    J Am Coll Cardiol; 2020 Jul; 76(1):1-13. PubMed ID: 32616150
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiopulmonary function during exercise in heart failure with reduced ejection fraction following baroreflex activation therapy.
    Nottebohm PI; Dumitrescu D; Hamacher S; Hohmann C; Madershahian N; Baldus S; Reuter H; Halbach M
    Ther Adv Cardiovasc Dis; 2022; 16():17539447221131203. PubMed ID: 36305639
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sympathetic and baroreflex alterations in congestive heart failure with preserved, midrange and reduced ejection fraction.
    Seravalle G; Quarti-Trevano F; Dell'Oro R; Gronda E; Spaziani D; Facchetti R; Cuspidi C; Mancia G; Grassi G
    J Hypertens; 2019 Feb; 37(2):443-448. PubMed ID: 30020242
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [New Technologies and Devices of Heart Failure with Reduced Ejection Fraction].
    Fan X; He Q; Feng S; Wang J
    Zhongguo Yi Liao Qi Xie Za Zhi; 2023 Feb; 47(2):185-189. PubMed ID: 37096473
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Baroreflex activation therapy: a new treatment option for heart failure with reduced ejection fraction.
    Halbach M; Hickethier T; Madershahian N; Müller-Ehmsen J
    Expert Rev Cardiovasc Ther; 2014 Dec; 12(12):1465-9. PubMed ID: 25382103
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Baroreflex Activation Therapy in Heart Failure With Reduced Ejection Fraction: Available Data and Future Perspective.
    Halbach M; Fritz T; Madershahian N; Pfister R; Reuter H
    Curr Heart Fail Rep; 2016 Apr; 13(2):71-6. PubMed ID: 26879389
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiac Contractility Modulation and Baroreflex Activation Therapy in Heart Failure Patients.
    Mann JA; Abraham WT
    Curr Heart Fail Rep; 2019 Feb; 16(1):38-46. PubMed ID: 30762177
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term chronic baroreflex activation: persistent efficacy in patients with heart failure and reduced ejection fraction.
    Gronda E; Seravalle G; Trevano FQ; Costantino G; Casini A; Alsheraei A; Lovett EG; Vanoli E; Mancia G; Grassi G
    J Hypertens; 2015 Aug; 33(8):1704-8. PubMed ID: 26132760
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Baroreflex activation therapy for the treatment of heart failure with reduced ejection fraction in patients with and without coronary artery disease.
    Halbach M; Abraham WT; Butter C; Ducharme A; Klug D; Little WC; Reuter H; Schafer JE; Senni M; Swarup V; Wachter R; Weaver FA; Wilks SJ; Zile MR; Müller-Ehmsen J
    Int J Cardiol; 2018 Sep; 266():187-192. PubMed ID: 29705650
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessment of baroreflex sensitivity has no prognostic value in contemporary, optimally managed patients with mild-to-moderate heart failure with reduced ejection fraction: a retrospective analysis of 5-year survival.
    Paleczny B; Olesińska-Mader M; Siennicka A; Niewiński P; Nowak K; Buldańczyk A; Jankowska EA; Banasiak W; von Haehling S; Ponikowska B; Anker SD; Ponikowski P
    Eur J Heart Fail; 2019 Jan; 21(1):50-58. PubMed ID: 30191647
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Baroreflex activation therapy in patients with heart failure with reduced ejection fraction: a single-centre experience.
    Blanco C; Madej T; Mangner N; Hommel J; Grimm S; Knaut M; Linke A; Winzer EB
    ESC Heart Fail; 2023 Dec; 10(6):3373-3384. PubMed ID: 37667319
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chronic baroreflex activation: a potential therapeutic approach to heart failure with preserved ejection fraction.
    Georgakopoulos D; Little WC; Abraham WT; Weaver FA; Zile MR
    J Card Fail; 2011 Feb; 17(2):167-78. PubMed ID: 21300307
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Restoration of normal sympathetic neural function in heart failure following baroreflex activation therapy: final 43-month study report.
    Dell'Oro R; Gronda E; Seravalle G; Costantino G; Alberti L; Baronio B; Staine T; Vanoli E; Mancia G; Grassi G
    J Hypertens; 2017 Dec; 35(12):2532-2536. PubMed ID: 28816745
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exercise training improves cardiac autonomic control, cardiac function, and arrhythmogenesis in rats with preserved-ejection fraction heart failure.
    Andrade DC; Arce-Alvarez A; Toledo C; Díaz HS; Lucero C; Schultz HD; Marcus NJ; Del Rio R
    J Appl Physiol (1985); 2017 Sep; 123(3):567-577. PubMed ID: 28620053
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Misconceptions and Facts about Heart Failure with Reduced Ejection Fraction.
    Krittanawong C; Rodriguez M; Lui M; Misra A; Tang WHW; Bozkurt B; Yancy CW
    Am J Med; 2023 May; 136(5):422-431. PubMed ID: 36740210
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Contemporary prevalence and correlates of incident heart failure with preserved ejection fraction.
    Gurwitz JH; Magid DJ; Smith DH; Goldberg RJ; McManus DD; Allen LA; Saczynski JS; Thorp ML; Hsu G; Sung SH; Go AS
    Am J Med; 2013 May; 126(5):393-400. PubMed ID: 23499328
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Baroreflex activation therapy for the treatment of heart failure with a reduced ejection fraction: safety and efficacy in patients with and without cardiac resynchronization therapy.
    Zile MR; Abraham WT; Weaver FA; Butter C; Ducharme A; Halbach M; Klug D; Lovett EG; Müller-Ehmsen J; Schafer JE; Senni M; Swarup V; Wachter R; Little WC
    Eur J Heart Fail; 2015 Oct; 17(10):1066-74. PubMed ID: 26011593
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modeling the physiological roles of the heart and kidney in heart failure with preserved ejection fraction during baroreflex activation therapy.
    Clemmer JS; Pruett WA
    Am J Physiol Heart Circ Physiol; 2022 Sep; 323(3):H597-H607. PubMed ID: 35984764
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.